Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,...
Reexamination Certificate
2007-04-24
2007-04-24
Nickel, Gary B. (Department: 1646)
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
C514S002600, C530S330000
Reexamination Certificate
active
10845407
ABSTRACT:
The present invention relates to methods and compositions for counteracting and reversing disease-causing signaling defects in disorders with underlying signal transduction aberrations, including but not limited to rheumatoid arthritis.
REFERENCES:
patent: 2002/0045230 (2002-04-01), Rosen et al.
Perdriger et al., 1997, J Rheumatol., vol. 24, pp. 1272-1276.
Hossain et al., Neuroscience Res., 2000, vol. 36, pp. 285-290.
Auger I et al. Nature Med 2:306-310 (1996).
Harris ED. N. Engl J Med 322:1277-1289 (1990).
Galena E and Feinstein DL. FASEB J 13:2125-2137 (1999).
Denninger JW and Marletta MA. Biochim Biophys Acta 1411:334-350 (1999).
Nepom GT et al. Arthritis Rheum 32:15-21 (1989).
Gregersen PK et al. Arthritis Rheum 30:1205-1213 (1987).
Brown KA. Br J Rheumatol 27: 150-155, (1988).
Maurice MM et al. J Immunol 158: 1458-1465, (1997).
Cemerski S et al. J Biol Chem 277: 19585-19593, (2002).
Cemerski S et al. Eur J Immunol 33: 2178-2185, (2003).
Yamanishi Y et al. Proc Natl Acad Sci (USA) 99: 10025-10030, (2002).
Migita K et al. Immunology 103: 362-367, (2001).
Ueki Y et al. J Rheumatol 23: 230-236, (1996).
Rall LC et al. J Nutr Biochem 11: 581-584, (2000).
Jikimoto T et al. Mol Immunol 38: 765-772, (2001).
Gonzalez-Escribano MF et al. Hum Immunol 60: 1259-1265 (1999).
Valenzuela A et al. Hum Immunol 60:250-254 (1999).
Jenkinson et al. Br J Rheumatol 28:86-88 (1989).
Aisen PS et al. J Neurol Sci 161:66-69 (1998).
Basu et al., Immunity 14:303-313 (2001).
Cunningham et al., Exp Neurol 163: 457-468 (2000).
Colaco CB et al. Clin Exp Immunol 72:15-19 (1988).
Taneja V et al. Arthritis Res. 2, 205-207, (2000).
Holmdahl R. et al. Ageing Res Rev. 1, 135-147, (2002).
Holoshitz J et al. Science 219, 56-58, (1983).
Kyburz D and Corr M et al. Springer Semin Immunopathol, 25: 79-90 (2003).
Zamani et al., Am J Med genet 76: 183-194, 1998.
Seigel JM. Narcolepsy: A key role for hypocretins (orexins). Cell 98: 409-412, 1999.
Sánchez et al., J Autoimmunity 15: 441-449, 2000.
Misko et al., Anal Biochem 214: 11-16, 1993.
Sakaguchi N et al. Nature. 426: 454-460, (2003).
Allen M. Miles, Yan Chen, Michael W. Owens, and Matthew B Grisham. Fluorometric Determination of Nitric Oxide. Methods, 7, 40-47, 1995.
Baksh S, Burns K, Busaa J, and Michalak M. Expression and purification of recombinant and native calreticulin. Protein Expr Purif., 3, 322-331, 1992.
Chemelli RM et al. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 98: 437-451, 1999.
Dorak et al., Int J Cancer 65:134-139 (1996).
Harris G et al. Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med 47:689-699, 1985.
Henson PM, Bratton DL and Fadok V. The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2: 627-633, 2001.
Johnsson et al., J Mol Recognit., 8, 125-131, 1995.
Karlsson et al., J. Immunol. Methods, 200, 121-133. 1997.
Löfås et al.,. Biosensors & Bioelectronics, 10, 813-822, 1995.
Lysiak et al., J Biol Chem 270: 21919-21927, 1995.
Lin L, et al. Cell 98: 365-376, 1999.
Miles AM, Chen Y, Owens MW, and Grisham MB. Fluorometric determination of nitric oxide. Methods 7: 40-47, 1995.
Holoshitz Joseph
Ling Song
Medlen & Carroll LLP
Nickel Gary B.
Regents of the University of Michigan
Xie Xiaozhen
LandOfFree
Methods and compositions for the treatment of MHC-associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for the treatment of MHC-associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the treatment of MHC-associated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3758980